Oncology CROs in Canada
8 published
8 published CROs match Oncology in Canada.
Facilities in this set are in Laval, Montreal, Mississauga, Quebec City, and Toronto.
Capabilities that show up most often in this set: Clinical Operations, Phase I Clinical Trials, Phase II Clinical Trials, Regulatory Affairs, and Phase III Clinical Trials.
Matching companies
AltasciencesMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.- JSS Medical ResearchFull-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Scimega ResearchCanadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.
Sussex Research Laboratories Inc.Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
Sygnature DiscoverySygnature Discovery is an integrated drug discovery contract research organization offering target identification, hit-to-lead, lead optimization, computational design, protein science, and in vivo pharmacology services. The company partners with biotech and pharma clients across the US, Canada, the UK, and Europe.
Syneos HealthGlobal CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
Markdown mirror: /indications/oncology/canada.md